Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: A matched case-control study

The Lancet Respiratory Medicine

Volumn 2, Issue 6, 2014, Pages 464-471

  Domingues, Carla Magda Allan S ^a,b   Verani, Jennifer R ^c   Montenegro Renoiner, Ernesto Issac ^a   de Cunto Brandileone, Maria Cristina ^d   Flannery, Brendan ^e   de Oliveira, Lucia Helena ^f   Santos, João Barberino ^b   de Moraes, José Cássio ^g   Rodrigues, Regina Coeli Magalhães ^h   Oliveira, Marluce Aparecida Assunção ^h   Ranieri, Tani Maria Schilling ^h   Zubaran, Gladys Maria ^h   Solon, Ana Lídia Lima ^h   de Aguiar Patrício, Maria Iracema ^h   de Oliveira, Maria Elisa Paula ^h   de Cássia Vilasboas Silva, Rita ^h   Wille, Marlene Sera ^h   Martinez, Pilar Gomes ^h   Sato, Helena Keico ^h   Bordim, Maria Cristina Hereny ^h   Careli, Luzia Auxiliadora ^h   da Glória Malheiros, Vera Lúcia ^h   da Silva Costa, Zenize Rocha ^h   da Silva, Maria Goretti Varejão ^h   Rodrigues, Cleidiane Santos ^h   Vieira, Ataiza César ^h   Watanabe, Lucila Tacacô ^h   Aires, Glaucia Gama Rahal ^h   de Almeida, Robmary Matias ^h   de Araújo Margarido, Diana Felicia ^h   de Souza, Ana Lúcia Stone ^h   Almeida, Samanta C G ^h   Brandão, Angela P ^h   Prado, Lincoln S ^h   Guerra, Maria Luiza L S ^h   Mantese, Orlando Cesar ^h   Berezin, Eitan ^h   Dias, Cicero ^h   Nascimento, Cristiana ^h   Reis, Joice ^h   Andrade, Ana Lucia ^h   Andrade, Solange ^h   Lobo, Flavia ^h   de Moraes, Camile ^h   de Barros, Eliane Castro ^h   de Carvalho, Márcia Lopes ^h   Correia, Elias Duarte Gonçalves ^h   Suzuki, Selma Lina ^h   more..

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

^e PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

^f PAN AMERICAN HEALTH ORGANIZATION   (United States)

^g HPV Institute   (Brazil)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE; VACCINE;

ARTICLE; BRAZIL; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; CLINICAL TRIAL; FOLLOW UP; IMMUNOLOGY; INCIDENCE; INFANT; MULTICENTER STUDY; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY;

BRAZIL; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84901754792     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70060-8     Document Type: Article

References (30)

1. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902. for the Hib and Pneumococcal Global Burden of Disease Study Team.
2. Vesikari T, Wysocki J, Chevallier B, et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 2009, 28(4 suppl):S66-S76.
3. World development indicators World Bank, (accessed Jan 12 2014). http://databank.worldbank.org/data/views/reports/tableview.aspx?isshared=true&ispopular=country&pid=4.
4. Brandileone MC, Vieira VS, Casagrande ST, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America. Microb Drug Resist 1997, 3:141-146.
5. SIREVA II (Sistema de Redes de Vigilancia de los Agentes Responsables de Neumonias y Meningitis Bacterianas) 2013 Pan American Health Organization, (accessed Aug 30 2013). http://www.paho.org/hq/index.php?option=com_content&view=category&layout=blog&id=3609&Itemid=3953.
6. Administrative rule number 104 2011 Brazilian Minstry of Health, (accessed Jan 12, 2014). http://bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt0104_25_01_2011.html.
7. Information system for notifiable diseases Brazilian Ministry of Health, (accessed Jan 12, 2014). http://dtr2004.saude.gov.br/sinanweb/.
8. Carvalho Mda G, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007, 45:2460-2466.
9. PCR deduction of pneumococcal serotypes Centers for Disease Control and Prevention, (accessed Sept 5, 2013). http://www.cdc.gov/ncidod/biotech/strep/pcr.htm.
10. Pimenta FC, Roundtree A, Soysal A, et al. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol 2013, 51:647-652.
11. Menezes AP, Reis JN, Ternes YM, et al. Update of pneumococcal PCR serotyping assay for detection of a commonly occurring type 19F wzy variant in Brazil. J Clin Microbiol 2013, 51:2470-2471.
12. REDE Interagencial de Informação para a Saúde (2011) Basic health indicators in Brazil Brazilian Minstry of Health, (accessed Nov 5, 2013). http://tabnet.datasus.gov.br/cgi/idb2011/matriz.htm.
13. Palmu AA, Jokinen J, Borys D, et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet 2013, 381:214-222.
14. Dagan R, Frasch C Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction. Pediatr Infect Dis J 2009, 28(4 suppl):S63-S65.
15. Prymula R, Schuerman L 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix. Expert Rev Vaccines 2009, 8:1479-1500.
16. Wysocki J, Tejedor JC, Grunert D, et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines. Pediatr Infect Dis J 2009, 28(4 suppl):S77-S88.
17. Bermal N, Szenborn L, Edison A, et al. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV/Hib and poliovirus vaccines. Pediatr Infect Dis J 2011, 30:69-72.
18. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368:1495-1502.
19. Mrkvan T, Hoet B, Adegbola RA, Van Dyke MK, Hausdorff WP Serotype 19A and the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV): Lessons learned to date 2013, European Society for Paediatric Infectious Diseases (ESPID), Milan.
20. Poolman J, Frasch C, Nurkka A, Käyhty H, Biemans R, Schuerman L Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines. Clin Vaccine Immunol 2011, 18:327-336.
21. Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, Andrade AL, Di Fabio JL Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. J Med Microbiol 2006, 55(pt 5):567-574.
22. Brandileone MC, de Andrade AL, Di Fabio JL, Guerra ML, Austrian R Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. J Infect Dis 2003, 187:1206-1212.
23. Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ Dynamic models of pneumococcal carriage and the impact of the heptavalent pneumococcal conjugate vaccine on invasive pneumococcal disease. BMC Infect Dis 2010, 10:90.
24. Goldblatt D, Southern J, Ashton L, et al. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 2006, 25:312-319.
25. Barata RB, Ribeiro MC, de Moraes JC, Flannery B Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008. J Epidemiol Community Health 2012, 66:934-941.
26. Afonso ET, Minamisava R, Bierrenbach AL, et al. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil. Emerg Infect Dis 2013, 19:589-597.
27. Neves FP, Pinto TC, Correa MA, et al. Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine. BMC Infect Dis 2013, 13:318.
28. De Wals P, Lefebvre B, Defay F, Deceuninck G, Boulianne N Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine 2012, 30:6416-6420.
29. Tregnaghi MW, Sáez-Llorens X, López P, et al. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) against invasive pneumococcal disease in Latin America. 9th International Symposium on Antimicrobial Agents and Resistance; Kuala Lumpur, Malaysia; March 13-15, 2013; 2013.
30. Pneumococcal vaccines WHO position paper-2012. Wkly Epidemiol Rec 2012, 87:129-144. WHO.